1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
    Journal Article

    Hughes, T. P.; Saglio, G.; Quintás-Cardama, A.; Mauro, M. J.; Kim, D. W.; Lipton, J. H.; Bradley-Garelik, M. B.; Ukropec, J.; Hochhaus, A.
    Leukemia (2015)

    Fulltext@MSK | Save
  • Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial
    Journal Article

    Bielack, S. S.; Werner, M.; Tunn, P. U.; Helmke, K.; Jürgens, H.; Calaminus, G.; Gerss, J.; Butterfass-Bahloul, T.; Reichardt, P.; Smeland, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Opportunistic testing versus organized prostate-specific antigen screening: Outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial
    Journal Article

    Arnsrud Godtman, R.; Holmberg, E.; Lilja, H.; Stranne, J.; Hugosson, J.
    European Urology (2015)

    Fulltext@MSK | Save
  • Effect of propofol on the medial temporal lobe emotional memory system: A functional magnetic resonance imaging study in human subjects
    Journal Article

    Pryor, K. O.; Root, J. C.; Mehta, M.; Stern, E.; Pan, H.; Veselis, R. A.; Silbersweig, D. A.
    British Journal of Anaesthesia (2015)

    Fulltext@MSK | Save
  • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial
    Journal Article

    Ribas, A.; Puzanov, I.; Dummer, R.; Schadendorf, D.; Hamid, O.; Robert, C.; Hodi, F. S.; Schachter, J.; Pavlick, A. C.; Lewis, K. D.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Beneficial effects of perioperative statins for major pulmonary resection
    Journal Article

    Amar, D.; Park, B.; Zhang, H.; Shi, W.; Fleisher, M.; Thaler, H. T.; Rusch, V. W.
    Journal of Thoracic and Cardiovascular Surgery (2015)

    Fulltext@MSK | Save
  • Goal-directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection: A randomized clinical trial
    Meeting Abstract

    Correa-Gallego, C.; Tan, K. S.; Arslan Carlon, V.; Gonen, M.; Denis, S. C.; Langdon-Embry, L.; Grant, F.; Kingham, T. P.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of the American College of Surgeons (2015)

    Fulltext@MSK | Save
  • Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma
    Journal Article

    Donati, O. F.; Do, R. K. G.; Hötker, A. M.; Katz, S. S.; Zheng, J.; Moskowitz, C. S.; Beattie, C.; Brown, K. T.
    European Radiology (2015)

    Fulltext@MSK | Save
  • A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer
    Journal Article

    Hussain, M.; Rathkopf, D.; Liu, G.; Armstrong, A.; Kelly, W. K.; Ferrari, A.; Hainsworth, J.; Joshi, A.; Hozak, R. R.; Yang, L.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save